| Symbol |
Name |
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ADD1
|
adducin 1 (alpha)
|
|
ADD3
|
adducin 3 (gamma)
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
ATF1
|
activating transcription factor 1
|
|
ATF4
|
activating transcription factor 4
|
|
ATM
|
ATM serine/threonine kinase
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
CCNE1
|
cyclin E1
|
|
CDC25A
|
cell division cycle 25A
|
|
CETN2
|
centrin, EF-hand protein, 2
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
DPYSL2
|
dihydropyrimidinase-like 2
|
|
EGFR
|
epidermal growth factor receptor
|
|
ELK1
|
ELK1, member of ETS oncogene family
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERCC3
|
excision repair cross-complementation group 3
|
|
ESR1
|
estrogen receptor 1
|
|
EZR
|
ezrin
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FSCN1
|
fascin actin-bundling protein 1
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GSK3A
|
glycogen synthase kinase 3 alpha
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
H2AFX
|
H2A histone family, member X
|
|
HERC2
|
HECT and RLD domain containing E3 ubiquitin protein ligase 2
|
|
HIST1H3A
|
histone cluster 1, H3a
|
|
IRS1
|
insulin receptor substrate 1
|
|
JUN
|
jun proto-oncogene
|
|
KAT5
|
K(lysine) acetyltransferase 5
|
|
KDR
|
kinase insert domain receptor
|
|
KRT18
|
keratin 18, type I
|
|
KRT8
|
keratin 8, type II
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2
|
|
MAPT
|
microtubule-associated protein tau
|
|
MCM2
|
minichromosome maintenance complex component 2
|
|
MDM4
|
MDM4, p53 regulator
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
NBN
|
nibrin
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PCBP1
|
poly(rC) binding protein 1
|
|
PDPK1
|
3-phosphoinositide dependent protein kinase 1
|
|
POLH
|
polymerase (DNA directed), eta
|
|
POLR2A
|
polymerase (RNA) II (DNA directed) polypeptide A, 220kDa
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
RAD17
|
RAD17 homolog (S. pombe)
|
|
RAD51
|
RAD51 recombinase
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RET
|
ret proto-oncogene
|
|
RPA2
|
replication protein A2, 32kDa
|
|
RPS6
|
ribosomal protein S6
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
SMAD3
|
SMAD family member 3
|
|
SMARCC2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 2
|
|
SMC1A
|
structural maintenance of chromosomes 1A
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
TP53
|
tumor protein p53
|
|
TRIM28
|
tripartite motif containing 28
|
|
TSC2
|
tuberous sclerosis 2
|
|
VASP
|
vasodilator-stimulated phosphoprotein
|
